Management of Diabetes during the US Pandemic: Focus on Blood Sugar Regulation
In a recent study published in JAMA Internal Medicine, researchers led by Ateev Mehrotra of Harvard Medical School in Boston, have delved into the impact of the COVID-19 pandemic on diabetes care. The study, which can be accessed here, compares the rates of diabetes-related health services received by patients with Type 2 diabetes before and during the pandemic.
The study's identifier is doi:10.1001/jamainternmed.2021.3047. For additional information, including the other authors, their contributions, affiliations, conflict of interest and financial disclosures, and funding and support, please refer to the article itself.
According to the research, the pandemic has had a significant impact on diabetes care. However, for specific details about the author of a separate study comparing diabetes-related health services for patients with Type 2 diabetes before and during the pandemic, more information is not currently available.
It's important to note that the article includes conflict of interest and funding/support disclosures, as outlined in the publication. For those interested in reading the full article, it can be accessed here.
This research adds to the growing body of evidence highlighting the need for continued attention and resources to ensure quality diabetes care, even during times of global health crises.
